ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Multiple Sclerosis
Sclerosis
Chronic Progressive Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Neoplasm Metastasis
Autoimmune Diseases
Alzheimer Disease

Multiple Sclerosis (MS) trials near San Diego, CA, USA:

A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis

This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple...

Active, not recruiting
Multiple Sclerosis, Relapsing-Remitting
Drug: Interferon beta type 1a
Drug: BIIB017 (peginterferon beta-1a)

Phase 3

Biogen
Biogen

La Jolla, California, United States and 64 other locations

This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...

Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
Drug: Ocrelizumab
Drug: Fingolimod

Phase 3

Roche
Roche

La Jolla, California, United States and 105 other locations

Locations recently updated

The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).

Enrolling
B-cell Mediated Autoimmune Disorders
Drug: Azercabtagene zapreleucel (azer-cel)

Phase 1

TG Therapeutics
TG Therapeutics

La Jolla, California, United States and 4 other locations

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Remibrutinib

Phase 3

Novartis
Novartis

Chula Vista, California, United States and 241 other locations

A Phase I Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis to demonstrate safety \& eff...

Not yet enrolling
Multiple Sclerosis
Biological: NeuroVax
Biological: IFA Incomplete Freund's Adjuvant

Phase 1

Immune Response BioPharma

San Diego, California, United States

This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥1...

Enrolling
Secondary Progressive Multiple Sclerosis
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Placebo

Phase 3

Sanofi
Sanofi

La Jolla, California, United States and 315 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems